|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.600
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.489
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.474
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.456
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.387
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.379
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.362
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.325
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.268
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.267
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.255
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.253
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.250
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.250
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.249
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.242
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.238
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.232
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.230
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.201
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.195
|
Mouse |
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.191
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.190
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.188
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.183
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.179
|
Mouse |
|
|
angiogenesis
|
GO:0001525 |
201 |
0.176
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.172
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.171
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.170
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.170
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.170
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.163
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.163
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.159
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.155
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.155
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.153
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.152
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.152
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.151
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.151
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.148
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.147
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.141
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.140
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.139
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.138
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.136
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.136
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.134
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.133
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.132
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.131
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.130
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.130
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.130
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.127
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.125
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.124
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.123
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.122
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.122
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.122
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.120
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.120
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.114
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.108
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.108
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.105
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.104
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.102
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.102
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.099
|
Mouse |
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.097
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.097
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.096
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.096
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.096
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.094
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.091
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.090
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.090
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.090
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.090
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.089
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.088
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.087
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.086
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.085
|
|
|
|
regulation of transforming growth factor beta secretion
|
GO:2001201 |
1 |
0.085
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.084
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.084
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.084
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.083
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.082
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.082
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.081
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.081
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.081
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.080
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.080
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.079
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.078
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.078
|
Mouse |
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.078
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.078
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.077
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.077
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.076
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.075
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.075
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.074
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.074
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.073
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.073
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.073
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.073
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.072
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.071
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.071
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.071
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.070
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.070
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.070
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.069
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.068
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.068
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.068
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.068
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.067
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.066
|
Mouse |
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.066
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.065
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.065
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.064
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.064
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.064
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.063
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.063
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.063
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.063
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.062
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.062
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.062
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.061
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.061
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.061
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.060
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.060
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.060
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.060
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.059
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.059
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.059
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.058
|
Mouse |
|
|
organelle localization
|
GO:0051640 |
179 |
0.058
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.057
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.057
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.056
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.056
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.056
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.055
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.055
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.055
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.054
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.053
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.052
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.052
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.052
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.052
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.052
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.052
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.051
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.051
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.051
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.050
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.050
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.050
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.049
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.049
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.049
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.049
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.049
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.048
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.048
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.048
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.048
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.048
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.047
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.047
|
|
|
|
positive regulation of transforming growth factor beta secretion
|
GO:2001203 |
1 |
0.047
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.047
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.047
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.046
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.046
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.046
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.046
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.046
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.046
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.046
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.045
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.045
|
Mouse |
|
|
cell adhesion
|
GO:0007155 |
329 |
0.045
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.045
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.045
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.045
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.044
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.044
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.044
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.044
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.044
|
Mouse |
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.043
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.043
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.043
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.043
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.043
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.043
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.043
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.042
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.042
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.042
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.042
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.042
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.042
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.042
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.041
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.041
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.041
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.041
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.040
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.040
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.040
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.040
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.040
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.040
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.040
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.040
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.040
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.040
|
Mouse |
|
|
organic acid transport
|
GO:0015849 |
101 |
0.039
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.039
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.039
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.039
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.039
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.039
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.039
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.039
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.039
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.039
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.038
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.038
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.038
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.038
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.038
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.038
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.037
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.037
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.037
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.037
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.037
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.037
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.037
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.037
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.037
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.037
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.036
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.036
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.036
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.036
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.036
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.036
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.035
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.035
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.035
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.035
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.035
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.035
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.035
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.034
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.034
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.034
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.034
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.034
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.034
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.034
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.034
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.034
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.034
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.034
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.034
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.033
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.033
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.033
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.033
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.033
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.033
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.033
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.033
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.033
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.033
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.033
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.033
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.033
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.032
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.032
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.032
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.032
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.032
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.032
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.032
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.032
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.031
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.031
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.031
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.031
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.031
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.031
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.031
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.031
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.031
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.031
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.031
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.031
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.030
|
Mouse |
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.030
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.030
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.030
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.030
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.030
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.030
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.030
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.030
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.030
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.029
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.029
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.029
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.029
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.029
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.029
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.029
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.029
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.028
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.028
|
|
|
|
negative regulation of growth of symbiont involved in interaction with host
|
GO:0044146 |
19 |
0.028
|
|
|
|
fat cell proliferation
|
GO:0070341 |
4 |
0.028
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.028
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.028
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.028
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.028
|
|
|
|
regulation of camp mediated signaling
|
GO:0043949 |
7 |
0.028
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.028
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.027
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.027
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.027
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.027
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.027
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.027
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.027
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.027
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.027
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.027
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.026
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.026
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.026
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.026
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.026
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.026
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.026
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.026
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.026
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.026
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.026
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.026
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.026
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.026
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
23 |
0.026
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.026
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.026
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.026
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.026
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.025
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.025
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.025
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.025
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.025
|
|
|
|
histamine transport
|
GO:0051608 |
2 |
0.025
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.025
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.025
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.025
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.025
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.025
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.025
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.025
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.024
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.024
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.024
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.024
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.024
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.024
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.024
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.024
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.024
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.024
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.024
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.024
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.024
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.024
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.024
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.024
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.024
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.024
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.024
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.024
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.024
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.024
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.024
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.023
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.023
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.023
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.023
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.023
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.023
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.023
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.023
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.023
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.023
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.023
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.023
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.023
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.023
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.023
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.023
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.023
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.023
|
|
|
|
regulation of actin filament bundle assembly
|
GO:0032231 |
18 |
0.023
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.022
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.022
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.022
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.022
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.022
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.022
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.022
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.022
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.022
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.022
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.022
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.022
|
|
|
|
growth involved in symbiotic interaction
|
GO:0044110 |
23 |
0.022
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.022
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.022
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.022
|
|
|
|
regulation of fat cell proliferation
|
GO:0070344 |
4 |
0.022
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.022
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.022
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.022
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.022
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.022
|
|
|
|
serotonin secretion involved in inflammatory response
|
GO:0002442 |
4 |
0.022
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.022
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.022
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.022
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.022
|
|
|
|
neutrophil mediated immunity
|
GO:0002446 |
19 |
0.022
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.021
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.021
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.021
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.021
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.021
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.021
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.021
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.021
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.021
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.021
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.021
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.021
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.021
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.021
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.021
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.021
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.021
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.021
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.021
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.021
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.021
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.021
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.021
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.021
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.020
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.020
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.020
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.020
|
|
|
|
regulation of serotonin secretion
|
GO:0014062 |
3 |
0.020
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.020
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.020
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.020
|
|
